Sodium, Serum
Phosphorus (Phosphate), Serum
Amikacin, Peak, Serum
Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Avantect Ovarian Cancer Test
Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)
Vitamin K1
Legionella pneumophilia antigen, DFA
DNA Methylation Gene Panel for Barrett's Esophagus (EndoSign®)
Apolipoprotein L1 (APOL1) Genotyping for Chronic Kidney Diseases
LDS
Sign up
Log in
LDS
/
Medical Tests
/
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
Medical Test
Methodology
Access to
Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Analysis in Bladder Cancer
is restricted.
Sign up now
Loading...